Epigallocatechin‐3‐O‐Gallate Ameliorates Oxidative Stress‐Induced Chondrocyte Dysfunction and Exerts Chondroprotective Effects via the Keap1/Nrf2/ARE Signaling Pathway

Wenrun Zhu,Han Tang,Lu Cao,Jin Zhang,Juncheng Li,Duan Ma,Changan Guo
DOI: https://doi.org/10.1111/cbdd.14056
2022-04-15
Abstract:In this study, we investigated the antioxidant and chondroprotective effects of EGCG on interleukin (IL)‐1β‐treated chondrocytes, and found Keap1/Nrf2/ARE pathway was involved. The results provide novel insights into the molecular mechanism involved in the therapeutic effects of EGCG in OA, which might broaden its application to the treatment of degenerative diseases.Oxidative stress‐induced degeneration and dysfunction of chondrocytes plays a key role in the pathological progression of osteoarthritis (OA), a common degenerative joint disease in the elderly. Epigallocatechin‐3‐O‐gallate (EGCG) increases Nrf2‐mediated antioxidase expression levels. We aimed to determine the effects of EGCG on C28/I2 human chondrocytes subjected to interleukin‐1β (IL‐1β)‐induced oxidative stress. EGCG suppressed IL‐1β‐induced oxidative stress, as indicated by decreased malondialdehyde (MDA) and reactive oxygen species (ROS) generation. Additionally, EGCG attenuated the IL‐1β‐induced reduction in cartilage matrix generated by chondrocytes by upregulationg collagen II, aggrecan, sulfated proteoglycans, and SRY‐box transcription factor 9 (SOX9). EGCG reversed the IL‐1β‐induced increased cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), collagen X, and matrix metalloproteinases (MMPs). Furthermore, EGCG inhibited apoptosis and senescence of IL‐1β‐treated chondrocytes, as indicated by the decrease in mitochondrial membrane potential and senescence‐associated β‐galactosidase‐positive cells, respectively. Mechanically, EGCG upregulated nuclear factor erythroid 2‐related factor 2 (Nrf2), oxygenase‐1 (HO‐1), and NADPH quinone oxidoreductase1 (NQO1). The antioxidant and chondroprotective effects of EGCG were blocked by ML385, a Keap1/Nrf2/ARE signaling pathway inhibitor. Thus, EGCG ameliorated oxidative stress‐induced chondrocyte dysfunction and exerted chondroprotective effects via Keap1/Nrf2/ARE signaling. This provides a novel perspective on the molecular mechanisms underlying the therapeutic effects of EGCG on OA.
What problem does this paper attempt to address?